What's new

Overview of comments received on guideline on clinical investigation of medicinal products in the treatment of epileptic disorders (CHMP/EWP/566/98 Rev.3)

Overview of comments received on guideline on clinical investigation of medicinal products in the treatment of epileptic disorders (CHMP/EWP/566/98 Rev.3)

Apr 28, 2025 - 12:38
 0
Overview of comments received on guideline on clinical investigation of medicinal products in the treatment of epileptic disorders (CHMP/EWP/566/98 Rev.3)
Read More

Tags:

Previous Article

Clinical investigation of medicinal products in the treatment of epileptic disor...

Next Article

pierre cardin presents its Pre Spring 2026 Collection: L'APPEL DU MATIN

Related Posts

Human medicines European public assessment report (EPAR): Ahzantive, aflibercept, Date of authorisation: 13/01/2025, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 25, 2025  0

Human medicines European public assessment report (EPAR): Flixabi, infliximab, Date of authorisation: 26/05/2016, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0

Human medicines European public assessment report (EPAR): Eltrombopag Accord, eltrombopag, Date of authorisation: 28/03/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 23, 2025  0